Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution
Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838)
10/2000
10/18/2000CN1057456C Wind-dispelling ointment and preparation method thereof
10/18/2000CN1057453C Tongniaoling for diuresis
10/18/2000CN1057452C Pellet for generation of semen
10/18/2000CN1057450C Medical liquid and its preparation method
10/18/2000CN1057448C Method for prepn. of medicinal introducing bag for treating diabetes mellitus
10/18/2000CN1057447C Quick-acting antidiarrhea oral liquor for infant and preparation method thereof
10/18/2000CN1057446C Active lactobacillus capsule
10/18/2000CN1057445C Method for preparing anticancer bioactive peptide preparation
10/17/2000US6133460 Have primary amino substitutions on the 3-, 4-, 5-, and 8-positions of the psoralen which permit binding to nucleic acid of pathogens; conditions that photoactivate these psoralens result in inactivation of pathogens which contain nucleic acid
10/17/2000US6133431 Adsorbent for immunoglobulins and complexes thereof, adsorption method, and adsorption device
10/17/2000US6133028 For gene therapy
10/17/2000US6133025 Nucleic acid for episomal replication in mammalian cells; includes a cis-acting origin of replication sequence and the nuclear antigen 1 sequence linked to a promoter; for gene therapy
10/17/2000US6133024 Recombinant vector which codes for an rna capable of forming a triple helix with target nucleic acid; for transcription of the rna in target cells
10/17/2000US6133017 Attenuated strain of Leishmania
10/17/2000US6133010 Chlamysin B antibacterial protein, a protein gene for and an expression system for same
10/17/2000US6133006 Nucleotide sequence coding an enzmatic polypeptide associated with signal transduction; for the diagnosis and treatment of osteoporosis, inflammation, skin disorders, asthma, nervous system disorders, cancer, eating disorders and infections
10/17/2000US6132980 Antibodies specific for TRP-2 a human tumor antigen recognized by cytotoxic T lymphocytes
10/17/2000US6132966 Enzymatic nucleic acid which specifically prevents viral replication; for the treatment of transformed hepatocytes and suppression of viral infection humans, animals and primates
10/17/2000US6132962 Plasmid coding ribozyme; for the prevention of viral infection
10/17/2000US6132789 For vaccine formulations as adjuvants and/or delivery systems, to enhance immune response to immunogens in animal such as human
10/17/2000US6132731 Murine leukemia virus vectors
10/17/2000US6132718 Using a vaccine comprising antibodies and anti-idiotype antibodies that mimic an epitope of antigen that is associated with a tumor or infectious agent.
10/17/2000US6132710 Preventing/treating neonatal NEC by administering lactobacillus salivarius and lactobacillus plantarum or a combination thereof
10/17/2000US6132709 Administering a fusobacterium necrophorum bacterin
10/17/2000US6132708 Liver regeneration using pancreas cells
10/17/2000US6132607 System for continuous magnetic separation of components from a mixture
10/17/2000CA1341119C Human erythroid-specific transcriptional enhancer
10/15/2000CA2305825A1 Novel bioactivating substance
10/12/2000WO2000060106A1 Use of helper-dependent adenoviral vectors of alternative serotypes permits repeat vector administration
10/12/2000WO2000060076A2 Compositions for the treatment and diagnosis of breast cancer and methods for their use
10/12/2000WO2000060054A1 Pharmaceutical compositions comprising circulating blood cells, preferably monocytes and uses thereof
10/12/2000WO2000060051A2 Arpe-19 as a platform cell line for encapsulated cell-based delivery
10/12/2000WO2000059941A1 Purposeful movement of human migratory cells away from an agent source
10/12/2000WO2000059916A1 Compounds selectively inhibiting gamma 9 delta 2 t lymphocytes
10/12/2000WO2000059536A1 Caspase inhibitors for inhibiting blood cell proliferation and for treating autoimmune diseases
10/12/2000WO2000059525A2 USE OF ErbB RECEPTOR LIGANDS IN TREATING DIABETES
10/12/2000WO2000059519A2 Active agent and combination of active agents for human beings and animals
10/12/2000WO2000059518A2 Composition and method for inducing apoptosis in prostate cancer cells
10/12/2000WO2000059515A2 Immunomodulating polymers
10/12/2000WO2000041576A8 Improved microbial preparations
10/12/2000WO2000038747A3 Absorbent article composition and method of use for sequestering skin irritants
10/12/2000WO2000033869A3 Use of human prostrate cell lines in cancer treatment
10/12/2000WO2000020587A3 Cancer associated antigens and uses therefor
10/12/2000CA2368017A1 Use of erbb receptor ligands in treating diabetes
10/12/2000CA2367390A1 Use of helper-dependent adenoviral vectors of alternative serotypes permits repeat vector administration
10/12/2000CA2366895A1 Immunomodulating polymers
10/12/2000CA2365825A1 Caspase inhibitors for inhibiting blood cell proliferation and for treating autoimmune diseases
10/12/2000CA2365221A1 Compositions for the treatment and diagnosis of breast cancer and methods for their use
10/12/2000CA2303702A1 Growth hormone and growth hormone releasing hormone compositions
10/11/2000EP1042495A1 Delivery of polypeptide-encoding plasmid dna into the cytosol of macrophages by attenuated suicide bacteria
10/11/2000EP1042493A1 Equine infectious anaemia virus (eiav) based retroviral vectors
10/11/2000EP1042000A1 Delivery of multiple genes to cells using plural adeno-associated viral vectors
10/11/2000EP1041994A1 Use of parasitic biological agents for prevention and control of autoimmune diseases
10/11/2000EP1041970A1 Compositions of microspheres for wound healing
10/11/2000EP1041882A1 Transvascular delivery of a composition to an extravascular tissue of a mammal
10/11/2000EP0700429B1 Retinal pigment epithelium transplantation
10/11/2000CN1269724A Absorption of minerals by intestinal cells
10/11/2000CN1269723A Maternal immue secretions and their use in treatment and/or prophylaxis of conditions of human body
10/11/2000CN1269241A Chiense medicine for treating hepatitis B together with aweto-cephalosporin mycelium and its preparation
10/11/2000CN1269236A External-use ointment for treating burns and scalds
10/11/2000CN1269222A Myopia treating medicine
10/11/2000CN1269221A Anticarcinogen injecta and its preparation
10/11/2000CN1269218A Medicated health tea
10/11/2000CN1269216A Tendon injure treating spray and its preparation
10/11/2000CN1269214A Thrombus dissolving capsule
10/11/2000CN1269208A Liver ascites treating syrup
10/11/2000CN1057231C Modulation of AIDS virus-related events by double-stuanded RNAs
10/11/2000CN1057230C Chinese medicine capsule for treating thrombophlebitis
10/11/2000CN1057228C Ointment for trauma and fracture and its preparation method thereof
10/11/2000CN1057224C Rendu kidney-tonifying wine
10/11/2000CN1057217C Seabuckthorn fruit yolk health oil and its producing method
10/11/2000CN1057216C Medicine for treating diabetes
10/11/2000CN1057214C Cooling throat oral liquor and preparation technology
10/11/2000CN1057213C Chinese medicinal preparation for treating skin diseases
10/11/2000CN1057212C Oral liquor for body-building
10/10/2000US6130087 Methods for generating cytotoxic T cells in vitro
10/10/2000US6130066 Vectors having enhanced expression and methods of making and uses thereof
10/10/2000US6130062 Production of proteins in host cells
10/10/2000US6129934 Modification of animal lung surfactant for treating respiratory disease due to lung surfactant deficiency or dysfunction
10/10/2000US6129926 Flash flow processing of thermoplastic polymers and products made therefrom
10/10/2000US6129912 Polyethylene glycol-protein compositions which reduce the antigenic display of red blood cells
10/10/2000US6129911 Liver stem cell
10/10/2000US6129848 Such as blood components from whole blood sample, by agitating a mixture of the component and magnetic particles to attach one of the components; adding to a magnetic separation apparatus to capture magnetic particle-component
10/10/2000CA2020346C Antibiotic ge 2270 factors a1, a2, a3 and h
10/05/2000WO2000058496A1 50 human secreted proteins
10/05/2000WO2000058494A1 50 human secreted proteins
10/05/2000WO2000058473A2 Nucleic acids including open reading frames encoding polypeptides; 'orfx'
10/05/2000WO2000058470A1 Prostate-specific gene, pcgem1, and methods of using pcgem1 to detect, treat, and prevent prostate cancer
10/05/2000WO2000058350A1 49 human secreted proteins
10/05/2000WO2000058341A1 Hookworm platelet inhibitor
10/05/2000WO2000058005A2 Immunoadsorber for use in sepsis therapy
10/05/2000WO2000057922A1 Intramyocardial injection of autologous bone marrow
10/05/2000WO2000057921A2 Peroral gene therapy of diabetes and obesity
10/05/2000WO2000057920A2 Method for expressing proteins
10/05/2000WO2000057912A1 Novel porcine protein and uses thereof
10/05/2000WO2000057891A1 Compositions and methods for producing platelets and/or proplatelets from megakaryocytes
10/05/2000WO2000057861A2 Use of cytidine derivatives for the treatment of leukaemia
10/05/2000WO2000057837A2 Compositions and methods for effecting the levels of cholesterol
10/05/2000WO2000057719A1 Additives for crustacean or fish feeds and feeds
10/05/2000WO2000057705A1 In vitro induction of antigen-specific t-cells using dendritic cell-tumor cell or dendritic cell-viral cell derived immunogens
1 ... 1045 1046 1047 1048 1049 1050 1051 1052 1053 1054 1055 1056 1057 1058 1059 1060 1061 1062 1063 1064 1065 ... 1259